Canada markets close in 4 hours 36 minutes

InnoCan Pharma Corporation (IP4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1445-0.0015 (-1.03%)
As of 03:12PM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
1,440
-
2,559
196
8
0
Cost of Revenue
919
-
452
75
5
0
Gross Profit
521
-
2,107
121
3
0
Operating Expenses
Research Development
1,480
-
1,526
1,399
1,744
368
Selling General and Administrative
6,171
-
6,847
6,202
2,984
2,633
Total Operating Expenses
7,651
-
8,373
7,601
4,728
3,001
Operating Income or Loss
-7,130
-
-6,266
-7,480
-4,725
-3,001
Interest Expense
4
-
2
13
8
334
Total Other Income/Expenses Net
3,806
-
2,359
-2,598
-5,220
-
Income Before Tax
-3,324
-
-3,888
-10,091
-9,953
-3,335
Income Tax Expense
0
-
1
0
0
0
Income from Continuing Operations
-3,324
-
-3,889
-10,091
-9,953
-3,335
Net Income
-3,129
-
-3,764
-10,047
-9,953
-3,335
Net Income available to common shareholders
-3,129
-
-3,764
-10,047
-9,953
-3,335
Basic EPS
-0.02
-0.02
-0.02
-0.05
-0.06
-
Diluted EPS
-0.02
-0.02
-0.02
-0.05
-0.06
-
Basic Average Shares
252,653
257,004
248,953
224,542
162,022
-
Diluted Average Shares
252,653
257,004
248,953
224,542
162,022
-